Tonya Cranford
Family · Greensboro, NCNPI 1659983930
Payments from drug & device makers
Across 325 payments — averaging $16.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$799
- Lilly USA, LLC$723
- Novo Nordisk$534
- GSK$425
- Astellas Pharma US Inc$327
- Mylan Specialty L.p.$289
- plus $2K from 33 others
What the payments were for
- Food & beverage$5,294100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 69 | $799 |
| Lilly USA, LLC | 42 | $723 |
| Novo Nordisk | 40 | $534 |
| GSK | 24 | $425 |
| Astellas Pharma US Inc | 20 | $327 |
| Mylan Specialty L.p. | 12 | $289 |
| Otsuka America Pharmaceutical, Inc. | 14 | $260 |
| AstraZeneca | 16 | $259 |
| Preventric Diagnostics, Inc. | 2 | $257 |
| Boehringer Ingelheim | 10 | $200 |
| Pfizer | 11 | $190 |
| Amarin Pharma, Inc. | 11 | $136 |
| Bayer | 8 | $127 |
| Amgen | 6 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $89 |
| Grifols USA, LLC | 3 | $68 |
| Lundbeck LLC | 3 | $58 |
| Esperion Therapeutics, Inc. | 3 | $49 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $43 |
| Sanofi Pasteur Inc. | 2 | $31 |
| Novartis | 2 | $25 |
| Insulet Corporation | 1 | $25 |
| Dexcom, Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Optinose US, Inc. | 1 | $20 |
| Ironwood Pharmaceuticals, Inc | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Merck | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Medtronic | 1 | $16 |
| Exact Sciences | 1 | $16 |
| Corium, LLC | 1 | $16 |
| Impel Pharmaceuticals Inc. | 1 | $16 |
| Irhythm Technologies, Inc. | 1 | $15 |
| Shield Therapeutics Inc | 1 | $15 |
| CSL Behring | 1 | $14 |
| Eisai Inc. | 1 | $13 |
| Avion Pharmaceuticals | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,294 in reported general payments places this provider in the 90th percentile of 4,522 family providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 45 | $52,093 |
| OzempicSemaglutide | 42 | $40,907 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $19,884 |
| JardianceEmpagliflozin | 15 | $16,979 |
| EliquisApixaban | 16 | $15,313 |
| TrulicityDulaglutide | 13 | $12,360 |
| Modafinil | 12 | $2,095 |
| Olmesartan Medoxomil | 80 | $2,019 |
| Rosuvastatin Calcium | 155 | $1,946 |
| Metformin Hcl ErMetformin Hcl | 94 | $1,663 |
| Levothyroxine Sodium | 105 | $1,593 |
| Montelukast Sodium | 70 | $1,529 |
| Bisoprolol Fumarate | 33 | $1,390 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 38 | $1,238 |
| Gabapentin | 84 | $1,175 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $723 | $64,45358 claims |
| Novo NordiskOzempic | $534 | $40,90742 claims |
| GSKTrelegy Ellipta | $425 | $19,88430 claims |
| Boehringer IngelheimJardiance | $200 | $16,97915 claims |
| PfizerEliquis | $190 | $15,31316 claims |
| AbbVieSynthroid | $799 | $84214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,522 family providers in North Carolina.
Other family in Greensboro
- Deanna MayGreensboro$61K
- Christine DaleGreensboro$12K
- Leslie ByrneFayetteville$482K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Nicole RothmanDurham$268K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Juanita PerkinsDurham$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.